Lindbrook Capital, LLC - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 32 filers reported holding AGEX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$117
-24.0%
1720.0%0.00%
Q2 2023$154
+35.1%
1720.0%0.00%
Q1 2023$114
+20.0%
1720.0%0.00%
Q4 2022$951720.0%0.00%
Q3 2022$01720.0%0.00%
Q2 2022$01720.0%0.00%
Q1 2022$01720.0%0.00%
Q4 2021$01720.00%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 2,997,156$1,654,1300.14%
Strategic Wealth Investment Group, LLC 86,440$60,5160.01%
Prescott General Partners LLC 185,185$102,2040.01%
Summit X, LLC 33,000$19,0150.01%
Beirne Wealth Consulting Services, LLC 18,000$9,9340.01%
Sigma Planning Corp 134,977$74,4940.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 169,770$93,6960.00%
UBS Group AG 13,502$7,4260.00%
NewEdge Advisors, LLC 1$00.00%
BNP PARIBAS FINANCIAL MARKETS 334$1840.00%
View complete list of AGEX THERAPEUTICS INC shareholders